INCLINE VILLAGE, Nev., Dec. 16, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced today that its Board of Directors has authorized a $75 million increase to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback